Scarica l'app Stockscreener
568.84
0.91%
1.8493
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché UTHR Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$566.99
Aprire:
$564.76
Volume 24 ore:
5,189
Relative Volume:
0.01
Capitalizzazione di mercato:
$24.91B
Reddito:
$3.18B
Utile/perdita netta:
$1.33B
Rapporto P/E:
20.39
EPS:
27.9001
Flusso di cassa netto:
$1.04B
1 W Prestazione:
-0.37%
1M Prestazione:
+9.44%
6M Prestazione:
+25.66%
1 anno Prestazione:
+90.24%
Intervallo 1D:
$561.00
$568.33
Intervallo di 1 settimana:
$560.16
$579.31
Portata 52W:
$272.12
$607.89
United Therapeutics Corp Stock (UTHR) Company Profile
Nome
United Therapeutics Corp
Settore
Telefono
(301) 608-9292
Indirizzo
1000 SPRING ST, SILVER SPRING, MD
Compare UTHR vs TAK, ZTS, HLN, TEVA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
568.33 | 24.94B | 3.18B | 1.33B | 1.04B | 27.90 |
TAK
Takeda Pharmaceutical Co Adr
|
16.29 | 51.84B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.50 | 49.05B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.145 | 42.09B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.75 | 36.82B | 17.41B | 1.43B | 1.00B | 1.2182 |
United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-10 | Iniziato | Raymond James | Outperform |
| 2025-10-20 | Iniziato | Wells Fargo | Underweight |
| 2025-09-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-06-02 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-04-21 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-07-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | Aggiornamento | Goldman | Sell → Neutral |
| 2024-02-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2022-12-06 | Iniziato | UBS | Buy |
| 2022-12-05 | Iniziato | Goldman | Sell |
| 2022-10-11 | Iniziato | Morgan Stanley | Overweight |
| 2022-09-20 | Reiterato | BofA Securities | Underperform |
| 2022-09-19 | Ripresa | Wedbush | Outperform |
| 2022-02-11 | Iniziato | BTIG Research | Neutral |
| 2021-07-14 | Aggiornamento | Argus | Hold → Buy |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-02-01 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | Ripresa | JP Morgan | Overweight |
| 2020-06-25 | Reiterato | H.C. Wainwright | Neutral |
| 2020-03-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-02-27 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-01-31 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-12-03 | Iniziato | BofA/Merrill | Underperform |
| 2019-08-01 | Aggiornamento | Jefferies | Underperform → Hold |
| 2019-08-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-09 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2018-08-08 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | Reiterato | Barclays | Underweight |
| 2018-01-18 | Ripresa | Credit Suisse | Underperform |
| 2017-12-27 | Reiterato | Wedbush | Outperform |
| 2017-04-27 | Reiterato | Wedbush | Outperform |
| 2017-03-30 | Iniziato | UBS | Sell |
| 2017-03-16 | Iniziato | Credit Suisse | Underperform |
Mostra tutto
United Therapeutics Corp Borsa (UTHR) Ultime notizie
United Therapeutics CEO Martine Rothblatt sells $5.4m in stock - Investing.com
United Therapeutics CEO Martine Rothblatt sells $5.4m in stock By Investing.com - Investing.com India
United Therapeutics CFO James Edgemond sells $5.69m in stock - Investing.com
United Therapeutics stock surges 32% in 6 months: Here's why - MSN
Firm working on pig-to-human transplants paid $8.5 million for 200 acres near Stewartville - Post Bulletin
United Therapeutics Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
United Therapeutics CEO Martine Rothblatt sells $5.37m in shares By Investing.com - Investing.com South Africa
Quent Capital LLC Buys 3,323 Shares of United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corporation $UTHR Shares Sold by Polaris Capital Management LLC - MarketBeat
United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors - The National Law Review
United Therapeutics CFO Edgemond sells $5.7 million in shares By Investing.com - Investing.com Australia
Insider Selling: United Therapeutics (NASDAQ:UTHR) CFO Sells 364 Shares of Stock - MarketBeat
United Therapeutics director Patusky sells $1.65m in shares By Investing.com - Investing.com India
United Therapeutics director Patusky sells $1.65m in shares - Investing.com
United Therapeutics CFO Edgemond sells $5.7 million in shares - Investing.com
M&T Bank Corp Boosts Holdings in United Therapeutics Corporation $UTHR - MarketBeat
China Universal Asset Management Co. Ltd. Reduces Position in United Therapeutics Corporation $UTHR - MarketBeat
Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
United Therapeutics CEO Martine Rothblatt sells $5.48m in shares By Investing.com - Investing.com India
United Therapeutics CEO Martine Rothblatt sells $5.48m in shares - Investing.com
United Therapeutics CEO Rothblatt sells $5.42 million in company stock - Investing.com
United Therapeutics CEO Rothblatt sells $5.42 million in company stock By Investing.com - Investing.com South Africa
United Therapeutics (UTHR) to Report Q1 Results: Wall Street Expects Earnings Growth - Yahoo Finance
United Therapeutics Bets on Manufactured Organs for Long-Term Growth - citybiz
Zurcher Kantonalbank Zurich Cantonalbank Purchases 32,689 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Novem Group Makes New $1.09 Million Investment in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (NASDAQ:UTHR) CFO Sells $5,778,600.00 in Stock - MarketBeat
United Therapeutics (NASDAQ:UTHR) CEO Sells $5,489,385.00 in Stock - MarketBeat
United Therapeutics CEO Rothblatt sells $5.57 million in stock By Investing.com - Investing.com South Africa
United Therapeutics CEO Rothblatt sells $5.57 million in stock - Investing.com
United Therapeutics to present research data at heart and lung conference - Investing.com
11 new studies on lung transplants, PH and xenotransplants head to ISHLT - Stock Titan
United Therapeutics Corporation (UTHR) Stock Analysis: A Robust Healthcare Play with a 9.47% Upside - DirectorsTalk Interviews
UTHR PE Ratio & Valuation, Is UTHR Overvalued - Intellectia AI
United Therapeutics Corporation (NASDAQ:UTHR) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Rothblatt, United Therapeutics CEO, sells $5.48 million in stock By Investing.com - Investing.com India
United Therapeutics (NASDAQ:UTHR) CFO Sells $5,771,800.00 in Stock - MarketBeat
Rothblatt, United Therapeutics CEO, sells $5.48 million in stock - Investing.com
United Therapeutics (NASDAQ:UTHR) Director Christopher Patusky Sells 1,000 Shares - MarketBeat
United Therapeutics (UTHR) director sells 1,000 shares after option exercise - Stock Titan
United Therapeutics (UTHR) CEO sells 9,500 shares under 10b5-1 plan - Stock Titan
United Therapeutics (UTHR) CFO sells 10,000 shares after option exercise - Stock Titan
[144] UNITED THERAPEUTICS Corp SEC Filing - Stock Titan
Martine Rothblatt Sells 75 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
Paul Mahon Sells 8,300 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
United Therapeutics (UTHR) CEO trades shares under Rule 10b5-1 plan - Stock Titan
United Therapeutics (UTHR) EVP & General Counsel sells 8,300 shares after option exercise - Stock Titan
UNITED THERAPEUTICS CORPORATION (UTHR) - MSN
Rothblatt, United Therapeutics CEO, sells $5.5 million in stock By Investing.com - Investing.com South Africa
Rothblatt, United Therapeutics CEO, sells $5.5 million in stock - Investing.com
United Therapeutics Corp Azioni (UTHR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
United Therapeutics Corp Azioni (UTHR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ROTHBLATT MARTINE A | Chairperson & CEO |
Apr 27 '26 |
Sale |
568.81 |
9,500 |
5,403,684 |
40,513 |
| EDGEMOND JAMES | CFO AND TREASURER |
Apr 27 '26 |
Option Exercise |
135.42 |
10,000 |
1,354,200 |
28,876 |
| EDGEMOND JAMES | CFO AND TREASURER |
Apr 27 '26 |
Sale |
568.83 |
10,000 |
5,688,319 |
18,876 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Apr 24 '26 |
Option Exercise |
146.03 |
9,500 |
1,387,285 |
50,013 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Apr 24 '26 |
Sale |
564.81 |
9,500 |
5,365,678 |
40,513 |
| EDGEMOND JAMES | CFO AND TREASURER |
Apr 23 '26 |
Option Exercise |
135.42 |
10,000 |
1,354,200 |
28,876 |
| EDGEMOND JAMES | CFO AND TREASURER |
Apr 23 '26 |
Sale |
572.21 |
9,636 |
5,513,830 |
18,876 |
| EDGEMOND JAMES | CFO AND TREASURER |
Apr 22 '26 |
Sale |
575.85 |
364 |
209,608 |
18,996 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Apr 23 '26 |
Option Exercise |
146.03 |
9,500 |
1,387,285 |
50,013 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Apr 23 '26 |
Sale |
572.35 |
9,500 |
5,437,340 |
40,513 |
0.74%
9.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):